Cyclerion Therapeutics Inc Financial Flexibility Index
Cyclerion Therapeutics Inc financial flexibility index. Cyclerion Therapeutics Inc (CYCN) has a Financial Flexibility Index of -0.74x as of June 2026. Free cash flow of $-1.37 Million (operating CF $-1.43 Million minus capex $66.00K) represents -1% of total liabilities ($1.84 Million). See Cyclerion Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cyclerion Therapeutics Inc (2016–2025)
Financial flexibility index of Cyclerion Therapeutics Inc from 2016 to 2025. Historical Financial Flexibility Index trend for Cyclerion Therapeutics Inc across 10 annual periods. Check how high is Cyclerion Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Cyclerion Therapeutics Inc Financial Flexibility Index by Year (2016–2025)
Cyclerion Therapeutics Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Cyclerion Therapeutics Inc. For the full cash flow conversion analysis, see CYCN cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.68x | $-3.31 Million | $-3.31 Million | $900.00K | ▲ +38.4% |
| 2024 | -5.98x | $-4.33 Million | $-4.33 Million | $725.00K | ▲ +41.3% |
| 2023 | -10.18x | $-21.25 Million | $-21.25 Million | $2.09 Million | ▼ -91.3% |
| 2022 | -5.32x | $-40.61 Million | $-40.61 Million | $7.63 Million | ▼ -61.7% |
| 2021 | -3.29x | $-36.51 Million | $-36.52 Million | $11.09 Million | ▼ -159.4% |
| 2020 | -1.27x | $-70.97 Million | $-72.49 Million | $55.88 Million | ▼ -18.2% |
| 2019 | -1.07x | $-95.33 Million | $-102.22 Million | $88.75 Million | ▲ +79.6% |
| 2018 | -5.27x | $-94.06 Million | $-97.50 Million | $17.85 Million | ▲ +7.3% |
| 2017 | -5.69x | $-79.81 Million | $-81.22 Million | $14.04 Million | ▼ -24.9% |
| 2016 | -4.55x | $-48.43 Million | $-49.87 Million | $10.64 Million | — |